Semaglutide Injections

Our semaglutide also has L-Carnitine which increases fat metabolism. Semaglutide is not stimulants like many weight loss medications. They work on hormone receptors in your body to help you lose weight. This works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food intake. The medication dose must be increased gradually over 16 to 20 weeks to reduce gastrointestinal side effects. Average weight loss is 6- 12% of your body weight. It is an injection weekly and increased slowly to prevent side effects.  Again, the semaglutide has not been FDA approved and it is a compounded medication.

The first month is $95 although this isn't covered by insurance, FSA/HSA can be used. 

Expected side effects can be the following, however they usually go away quickly

  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • constipation
  • heartburn

Semaglutide injection may increase the risk that you will develop tumors of the thyroid gland, including medullary thyroid carcinoma (MTC; a type of thyroid cancer). Laboratory animals who were given semaglutide developed tumors, but it is not known if this medication increases the risk of tumors in humans. Tell your doctor if you or anyone in your family has or has ever had MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2; condition that causes tumors in more than one gland in the body). If so, your doctor will probably tell you not to use semaglutide injection. If you experience any of the following symptoms, call your doctor immediately: a lump or swelling in the neck; hoarseness; difficulty swallowing; or shortness of breath. Patients should stop semaglutide immediately and seek medical help if a severe allergic reaction is suspected. Semaglutide also contains warnings for inflammation of the pancreas (pancreatitis), gallbladder problems (including gallstones), low blood sugar, acute kidney injury, diabetic retinopathy (damage to the eye's retina), increased heart rate and suicidal behavior or thinking. Patients should discuss with their healthcare professional if they have symptoms of pancreatitis or gallstones.